Novo Nordisk Corporate Center | Architect Magazine
Wegovy, the newest weight loss drug, comes with a high cost - Los Angeles Times
Who we Are | Novo Nordisk U.S.
Novo Nordisk (NVO) Rides on Ozempic & Wegovy Amid Rivalry
Novo Nordisk Foundation
Novo Nordisk Headquarters – ArcDog
Ozempic maker Novo Nordisk to acquire obesity drug developer in $1B deal | The Hill
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines | Science|Business
Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, Ozempic | Reuters
Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg
Novo Nordisk builds R&D capacity in cardiovascular and liver diseases | Science | AAAS
Find a job
Ozempic, Wegovy Maker Novo's Rise Forces Denmark to Keep Rates Lower: Danske - Bloomberg
Novo Nordisk investing $117.4M in manufacturing site in Denmark | Fierce Pharma
Novo Nordisk - JDRF
Novo Nordisk launches 'strong' guidance, warns of supply constraints | Reuters
Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service
Novo Nordisk - Our Headquarters in Denmark has turned orange to mark #WorldPatientSafetyDay 🧡 Stay safe, everyone! | Facebook
Novo Nordisk invests DKK 5.4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark - The Danish-UK Association
:max_bytes(150000):strip_icc()/GettyImages-1609713629-a18bedba0fc9458096ee57748e536c95.jpg "Novo Nordisk and Valo Health to Use AI to Develop Treatments for Cardiometabolic Diseases")
Novo Nordisk and Valo Health to Use AI to Develop Treatments for Cardiometabolic Diseases
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases | Fierce Biotech
Novo Nordisk launches smart insulin pen in Denmark — MedWatch
Henning Larsen | Novo Nordisk Global Head Office
400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work
Novo Nordisk Headquarters – ArcDog
Novo Nordisk invests €2.1bn in Hillerød manufacturing expansion
